ArticleDEN open2024
Cost-effectiveness analysis of the artificial intelligence diagnosis support system for early gastric cancers.
Article in DEN open, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers, 2 of them syntheses that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
15 citing papers in PubMed, 2 syntheses or guidelines pooled it, 24 citations in OpenAlex.
- Economic evaluation of AI-assisted technologies in healthcare: A systematic review.Journal of food and drug analysis · 2025Pooled it
- Opportunities, challenges, and requirements for Artificial Intelligence (AI) implementation in Primary Health Care (PHC): a systematic review.BMC primary care · 2025Pooled it
- Development and clinical assessment of a novel AI-based diagnostic model for Hirschsprung's disease.Updates in surgery · 2026Article
- World Endoscopy Organization Position Statements for Artificial Intelligence in Endoscopic Diagnosis of Gastric Epithelial Neoplasia.Digestive endoscopy : official journal of the Japan Gastroenterological Endoscopy Society · 2026Review
- Beyond diagnostic accuracy: navigating the artificial intelligence data tsunami toward value-based implementation in gastroenterology.Frontiers in artificial intelligence · 2026Review
- Artificial Intelligence in Gastrointestinal Endoscopy: Current Advances, Clinical Integration, and Future Directions: A Narrative Review.Clinical and experimental gastroenterology · 2026Review
- Current Role of Artificial Intelligence in the Management of Gastric Cancer.Biomedicines · 2025Review
- Challenges in clinical translation of artificial intelligence and real-time imaging navigation in radical gastrectomy.World journal of gastroenterology · 2025Review
- Artificial intelligence for diagnostics in radiology practice: a rapid systematic scoping review.EClinicalMedicine · 2025Article
- Artificial intelligence in gastrointestinal cancers: Diagnostic, prognostic, and surgical strategies.Cancer letters · 2025Review
- AI Era Is Coming: The Implementation of AI Medical Devices to Endoscopy.JMA journal · 2025Article
- Cost-effectiveness analysis of AI-assisted chest X-ray interpretation tools for TB screening: a rapid HTA.Frontiers in digital health · 2025Article
- Comparing Raman Spectroscopy-Based Artificial Intelligence to High-Definition White Light Endoscopy for Endoscopic Diagnosis of Gastric Neoplasia: A Feasibility Proof-of-Concept Study.Diagnostics (Basel, Switzerland) · 2024Article
- Applications of Artificial Intelligence-Based Systems in the Management of Esophageal Varices.Journal of personalized medicine · 2024Review
- Prediction of spontaneous distal ureteral stone passage using artificial intelligence.International urology and nephrology · 2024Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors at 5 institutions in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objectives: The introduction of artificial intelligence into the medical field has improved the diagnostic capabilities of physicians. However, few studies have analyzed the economic impact of employing artificial intelligence technologies in the clinical environment. This study evaluated the cost-effectiveness of a computer-assisted diagnosis (CADx) system designed to support clinicians in differentiating early gastric cancers from non-cancerous lesions in Japan, where the universal health insurance system was introduced. Methods: The target population to be used for the CADx was estimated as those with moderate to severe gastritis caused by Results: Compared with the status quo as represented in the base-case analysis, the incremental cost-effectiveness ratio of CADx in the Japanese market was forecasted to be 11,093 USD per quality-adjusted life year. The sensitivity analyses demonstrated that the expected incremental cost-effectiveness ratios were within the willingness-to-pay threshold of 50,000 USD per quality-adjusted life year when the cost of the CAD was less than 104 USD. Conclusions: Using CADx for EGCs may decrease their misdiagnosis, contributing to improved cost-effectiveness in Japan.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.